Structure of 235 Tri O benzyl D ribono 14 lactone CAS 55094 52 5 - 2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone CAS 55094-52-5

Iden­ti­fi­ca­tion

CAS Number

55094-52-5

Name

2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone

Syn­onyms

(3R,4R,5R)-3,4-Bis(benzyloxy)-5-[(benzyloxy)methyl]dihydro-2(3H)-fura­non [Ger­man] [ACD/IUPAC Name]
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-[(benzyloxy)methyl]dihydro-2(3H)-fura­none [ACD/IUPAC Name]
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-[(benzyloxy)méthyl]dihydro-2(3H)-fura­none [French] [ACD/IUPAC Name]
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)-methyl)dihydrofuran-2(3H)-one
(3r,4r,5r)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3h)-one(wxc00619)
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-[(benzyloxy)methyl]oxolan-2-one (non-pre­­ferred name)
(3R,4R,5R)-3,4-Bis(benzyloxy)-5-[(benzyloxy)methyl]oxolan-2-one ; 2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone
(3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-one
[55094-52-5]
14233-64-8 [RN]
2,?3,?5-?Tri-?O-?benzyl-?D-?ribonolactone
2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone
2,3,5-Tri-O-benzyl-D-ribonolactone
55094-52-5 [RN]
AKOS016002138
ANW-58676
CTK8B7811
MFCD08703966 [MDL num­ber]
Mol­Port-023-223-795
PubChem10807
QB-3869
SCHEMBL3304205

SMILES

C1=CC=C(C=C1)COC[C@@H]2[C@H]([C@H](C(=O)O2)OCC3=CC=CC=C3)OCC4=CC=CC=C4

Std­InChI

InChI=1S/C26H26O5/c27-26-25(30-18-22-14-8-3-9-15-22)24(29-17-21-12-6-2-7-13-21)23(31-26)19-28-16-20-10-4-1-5-11-20/h1-15,23-25H,16-19H2/t23-,24-,25-/m1/s1

Std­InChIKey

LDHB­S­AB­B­BAUM­CZ-UBFVS­LLYSA-N

Mol­e­c­u­lar Formula

C26H26O5

Mol­e­c­u­lar Weight

418.482

Prop­er­ties

Appear­ance

White to off-white powder

Melt­ing Point

51.6-52.6°C

Safe­ty Data

WGK Germany

3

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone CAS 55094-52-5

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Puri­ty(HPLC,UV)

98% min

Shelf Life

1 year

Stor­age

Store at cool place(≤20℃) , sealed and away from light.

Known Appli­ca­tion

Com­mon­ly used as an Remde­sivir intermediate.

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​2​,​3​,​5​-​t​r​i​-​o​-​b​e​n​z​y​l​-​d​-​r​i​b​o​n​o​-​1​,​4​-​l​a​c​t​o​n​e​-​c​a​s​-​5​5​0​9​4​-​5​2​-5/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the tree.